Healthcare sector M&A deals surge 85% in H1FY23: Grant Thornton
A few high-value transactions played a significant role in driving the total transaction value from $1.2 billion in Q1 2023 to $4.4 billion in H1 2023
A few high-value transactions played a significant role in driving the total transaction value from $1.2 billion in Q1 2023 to $4.4 billion in H1 2023
India’s life sciences R&D is undergoing a sea change. Given the huge risks and investments involved, can India taste success in innovative medicine, therapy and diagnostic tools?
The company, set up and funded by Sun Pharma founder and MD Dilip Shanghvi’s family office, is focusing on AI-led pharma research and development, even offering tech tools to the industry for R&D.
The Union Budget 2021 understands that for India to become the third-largest economy in the world, scientific research and innovation requires a policy boost.
Accenture’s INTIENT platform, powered by Google Cloud, help life sciences organisations make their data more accessible, secure, and valuable